Brussels, 22/04/2014 (Agence Europe) - On Tuesday 15 April, the second version of the European Innovative Medicines Initiative (IMI2) received the support of the European Parliament, which was consulted for its opinion only. The report by the MEP Riera Madurell (S&D, Spain) was adopted at the plenary session in Strasbourg by 560 votes in favour, 104 votes against and nine abstentions. Only the Greens/EFA group tabled amendments, but these were all rejected.
This initiative is based on the...